Adrenal Mass

Comprehensive evaluation and personalized management of adrenal tumors — from the moment an unexpected mass is found on imaging through hormonal workup, treatment planning, and long-term follow-up.

Understanding Adrenal Masses

The adrenal glands are small, triangular organs that sit on top of each kidney. Despite their size — each roughly the size of a walnut — they play a vital role in producing hormones that regulate blood pressure (aldosterone), the body's stress response (cortisol and adrenaline), and metabolism. An adrenal mass is an abnormal growth within one of these glands, and it can range from a tiny, harmless nodule to a rare malignant tumor.

How Common Are Adrenal Masses?

Adrenal masses are far more common than most people realize. An incidental adrenal tumor — called an adrenal incidentaloma — is found on approximately 5% of abdominal CT scans performed for completely unrelated reasons, such as evaluating abdominal pain or following up after an injury. Autopsy studies show that roughly 6% of all people have an adrenal mass they never knew about. The likelihood increases with age: fewer than 1% of people under age 30 have an incidentaloma, while up to 7% of people over age 60 do.

Types of Adrenal Masses

The vast majority — roughly 85% — of adrenal incidentalomas are benign, nonfunctional adenomas that do not produce excess hormones and do not require treatment. However, several other types of adrenal tumors exist and must be considered:

  • Adrenal adenoma — The most common type. Benign growths in the adrenal cortex (outer layer). Some adenomas produce excess cortisol or aldosterone, making them "functional."
  • Pheochromocytoma — A rare tumor arising from the adrenal medulla (inner core) that produces excess adrenaline and noradrenaline. Approximately 85–90% are benign, but they can cause dangerous surges in blood pressure, rapid heart rate, sweating, and headaches.
  • Adrenocortical carcinoma (ACC) — A rare but aggressive cancer of the adrenal cortex. ACC accounts for a small fraction of adrenal masses, but the risk increases with tumor size — roughly 2% for masses under 4 cm versus up to 25% for masses larger than 6 cm.
  • Metastases — In patients with a known cancer elsewhere in the body (such as lung, breast, or melanoma), an adrenal mass may represent a metastatic deposit rather than a primary adrenal tumor.
  • Other rare tumors — Including myelolipomas, ganglioneuromas, and adrenal cysts, most of which are benign and identifiable on imaging.

Functional vs. Nonfunctional Tumors

One of the most important distinctions is whether a mass is functional (producing excess hormones) or nonfunctional (hormonally silent). Functional tumors can cause serious health problems even when they are small and benign:

  • Cortisol excess (Cushing's syndrome) — Weight gain (especially in the face and trunk), high blood sugar, high blood pressure, muscle weakness, easy bruising, and mood changes.
  • Aldosterone excess (Conn's syndrome) — Severe or treatment-resistant high blood pressure, low potassium levels, muscle cramps, and increased risk of stroke and heart disease.
  • Catecholamine excess (pheochromocytoma) — Episodes of dangerously high blood pressure, rapid or pounding heartbeat, severe headaches, sweating, anxiety, and tremors.

All functional tumors require treatment — typically surgical removal — regardless of their size. Nonfunctional tumors may be safely monitored unless they are large or have suspicious imaging features.

When surgery is recommended, robotic adrenalectomy provides a minimally invasive approach with a magnified three-dimensional view, precise dissection around critical blood vessels, and a faster recovery compared to open surgery — with most patients going home within one to two days.

Evaluation Priorities

Hormonal Evaluation

Every adrenal mass requires a thorough biochemical workup — even when it appears incidental and harmless on imaging. Studies show that approximately 15% of adrenal incidentalomas turn out to be hormonally active, so testing is essential. The standard workup includes three key screenings:

  • Cortisol — An overnight 1-mg dexamethasone suppression test to check for excess cortisol production (Cushing's syndrome or subclinical cortisol excess).
  • Catecholamines/metanephrines — Plasma free metanephrines or a 24-hour urine collection for fractionated metanephrines and catecholamines to rule out pheochromocytoma. This test is critical before any surgical procedure on the adrenal gland.
  • Aldosterone and renin — An aldosterone-to-renin ratio in patients with high blood pressure or low potassium, to screen for primary aldosteronism (Conn's syndrome).

If any of these tests are abnormal, additional confirmatory testing may be needed before proceeding with treatment.

Size & Imaging Assessment

Dedicated adrenal-protocol CT imaging provides critical information for distinguishing benign adenomas from potentially dangerous masses. Key features we evaluate include:

  • Size — Tumor diameter is one of the strongest predictors of malignancy. The cancer risk is roughly 2% for masses under 4 cm, about 7% for masses between 4 and 6 cm, and up to 25% for masses over 6 cm.
  • Density (Hounsfield units) — Benign adenomas are typically lipid-rich and measure 10 Hounsfield units (HU) or less on an unenhanced CT scan. Masses above this threshold require further evaluation.
  • Contrast washout — Adenomas wash out contrast dye quickly (greater than 60% absolute washout at 15 minutes), while malignant tumors tend to retain contrast longer.
  • Growth over time — Any mass that grows more than 1 cm on follow-up imaging warrants reassessment and often surgical removal.

Surgical Decision-Making

Not every adrenal mass requires surgery. The decision is based on a combination of hormonal status, imaging characteristics, and the individual patient's health. Current guidelines recommend surgical removal (adrenalectomy) for:

  • All functional tumors producing excess hormones, regardless of size
  • Masses larger than 4 cm with indeterminate or suspicious imaging features
  • Any mass with imaging characteristics suggesting adrenocortical carcinoma or pheochromocytoma
  • Masses that show significant growth on surveillance imaging

Small, nonfunctional masses with clearly benign imaging features (low density, smooth borders) can typically be monitored safely with periodic imaging and repeat hormone testing. When surgery is the right choice, robotic adrenalectomy allows for precise tumor removal through small incisions, with most patients returning home within one to two days and back to normal activities within two to four weeks.

Your Care Pathway

Step 1

Mass Discovered

The journey typically begins when a CT scan or MRI ordered for an unrelated reason — such as abdominal pain, a kidney stone, or routine screening — unexpectedly reveals an adrenal mass. This happens in roughly 5% of all abdominal CT scans. Your referring physician or Dr. Radtke will review the imaging and begin a systematic evaluation to determine the nature of the mass.

Step 2

Hormonal Workup

A series of blood and urine tests are ordered to determine whether the mass is producing excess hormones. This typically includes an overnight dexamethasone suppression test (for cortisol), plasma free metanephrines or 24-hour urine catecholamines (for pheochromocytoma), and an aldosterone-to-renin ratio if you have high blood pressure. Even masses that appear benign on imaging can produce subtle hormone excess that affects your health over time, so this step is essential for every patient.

Step 3

Imaging Review

We carefully analyze the adrenal mass on dedicated adrenal-protocol CT imaging. Key characteristics include the mass size (the 4 cm threshold is an important benchmark), its density measured in Hounsfield units (benign adenomas are typically 10 HU or less), how quickly the mass washes out contrast dye, and whether the borders are smooth or irregular. These features together help us distinguish a harmless adenoma from a mass that may be a pheochromocytoma, adrenocortical carcinoma, or metastasis.

Step 4

Decision: Monitor vs. Surgery

After combining the hormonal results and imaging findings, we recommend one of two paths. For small (under 4 cm), nonfunctional masses with clearly benign imaging features, we recommend periodic surveillance — typically repeat imaging at 6 to 12 months and again at 24 months, along with repeat hormone testing. For masses that are functional, larger than 4 cm, growing, or have suspicious imaging characteristics, we recommend surgical removal. We walk through the rationale for whichever recommendation applies to you.

Step 5

Robotic Adrenalectomy

When surgery is the right course of action, robotic adrenalectomy is the preferred approach. The robotic platform provides a magnified three-dimensional view and articulating instruments that allow precise dissection around the adrenal gland's delicate blood vessels and nearby organs — including the kidney, vena cava, and pancreas. Surgery is performed through a few small incisions, and most patients go home within one to two days. If pheochromocytoma is suspected, special preoperative medications (alpha-blockers) are started two to four weeks before surgery to safely control blood pressure during the operation.

Step 6

Follow-Up & Recovery

After surgery, pathology results confirm the diagnosis and guide any further treatment. Most patients return to normal daily activities within two to four weeks. If the mass was producing excess cortisol, you may need temporary steroid replacement while your remaining adrenal gland recovers its normal function — a process that can take several months. For patients on surveillance, follow-up imaging and hormone testing continue at scheduled intervals to confirm stability. If a monitored mass grows by more than 1 cm or develops new hormonal activity, surgery is reconsidered at that point.

Schedule a Consultation

If an adrenal mass has been found on your imaging, Dr. Radtke can provide a thorough evaluation and guide you through the next steps — whether that means monitoring or surgical treatment.

Green Bay Office

Phone: (920) 456-3777

Sheboygan Office

Phone: (920) 456-3777

Schedule an Appointment

Dr. Radtke sees patients through Prevea Health. You can book an appointment online or call our office directly.